Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis
End-stage liver fibrosis is common to all chronic liver diseases. Since liver transplantation has several limitations, including lack of donors, immunological rejection, and high medical costs, therapeutic alternatives are needed. The administration of mesenchymal stromal cells (MSCs) has been prove...
Main Authors: | Giulia Chiabotto, Chiara Pasquino, Giovanni Camussi, Stefania Bruno |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2020.594794/full |
Similar Items
-
Extracellular Vesicles: A Therapeutic Option for Liver Fibrosis
by: Stefania Bruno, et al.
Published: (2020-06-01) -
Mesenchymal Stromal Cells Epithelial Transition Induced by Renal Tubular Cells-Derived Extracellular Vesicles.
by: Giulia Chiabotto, et al.
Published: (2016-01-01) -
Human Liver Stem Cells: A Liver-Derived Mesenchymal Stromal Cell-Like Population With Pro-regenerative Properties
by: Stefania Bruno, et al.
Published: (2021-04-01) -
Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth
by: Stefania eBruno, et al.
Published: (2014-08-01) -
Therapeutic Effects of an Inhibitor of Thioredoxin Reductase on Liver Fibrosis by Inhibiting the Transforming Growth Factor-β1/Smads Pathway
by: Wenxuan Jiao, et al.
Published: (2021-09-01)